RxDoctor Payments Data

Peter Chang, MD

Neuroradiology · San Francisco, CANPI 1841530458

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (52.9%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Bayer Healthcare LLC at 52.1% of the total. Reporting peaked in 2023 at $14,704 and has fallen 99.8% since, to $36 in 2025.

$27,960in general payments, 2019–2025

Across 31 payments — averaging $901.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Bayer Healthcare LLC$15K
  • Olea Medical$7K
  • Canon Medical Systems USA, Inc.$5K
  • Canon Medical Systems Corporation$850
  • Atricure, Inc.$461
  • Novocure Inc.$338
  • plus $120 from 2 others
$151,507in research payments, 2019–2025

Across 4 payments — averaging $37,877 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novocure Inc.$152K

What the payments were for

  • Consulting fees$14,78053%
  • Speaking & faculty fees$2,85010%
  • Grants$730%
  • Travel & lodging$9,01732%
  • Food & beverage$1,2404%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,960 in reported general payments places this provider in the 85th percentile of 154 neuroradiology providers in California.

See all neuroradiology providers in California

Medicare billing

Part B allowed, 2024
$53,609
Medicare patients
376
Services billed
835

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neuroradiology in San Francisco

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →